Glycomimetics (GLYC)
GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.1570
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- Price Alert · 37 minutes ago
U.S. Stock Market Midday Update: AARD up 12.22%! IPO misleading allegations lead to class action lawsuit, legal risks intensify market volatility
- MarketWatch Automated · 20 hours ago
Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
- MarketWatch Automated · 20 hours ago
Thermo Fisher Scientific Inc. Stock Rises Thursday, Outperforms Market
- TradingKey · 21 hours ago
Bristol-Myers Squibb Co Stock (BMY) Closed Down by 3.17% on Aug 20: Facts Behind the Movement
- Price Alert · 22 hours ago
U.S. Stock Market Midday Update: YD Bio Soars 109% in 10 Days Without Any Good News? Speculative Trading May Carry Adjustment Risks
- TradingKey · 1 day ago, 03:16 PM
Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement
